GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
E

Edwards Lifesciences EW · USD

Health Care · Health Care Equipment & Supplies · US listing · 🇺🇸 United States

S&P 500

Compare

104.71

+2.52%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Largest shareholders

As filed, so dates differ, and a group and its funds can both appear.

HolderSharesStakeChangeFiled
BLACKROCK, INC.52.6m8.98%+129k31 Mar 2026
VANGUARD CAPITAL MANAGEMENT LLC37.7m6.44%+37.7m31 Mar 2026
VANGUARD PORTFOLIO MANAGEMENT LLC26.4m4.51%+26.4m31 Mar 2026
STATE STREET CORP26.3m4.49%+304.9k31 Mar 2026
WELLINGTON MANAGEMENT GROUP LLP22m3.76%+217.2k31 Mar 2026
JPMORGAN CHASE & CO21.7m3.71%−4.3m31 Mar 2026
BANK OF NEW YORK MELLON CORP16.7m2.86%−755k31 Mar 2026
FMR LLC14.5m2.48%−2.1m31 Mar 2026
GEODE CAPITAL MANAGEMENT, LLC13.1m2.24%+348.9k31 Mar 2026
JENNISON ASSOCIATES LLC13.1m2.23%−714.2k31 Mar 2026
DZ BANK AG DEUTSCHE ZENTRAL GENOSSENSCHAFTS BANK, FRANKFURT AM MAIN12.8m2.19%+5.1m31 Mar 2026
NINETY ONE UK LTD12.4m2.12%+4.7m31 Mar 2026
MORGAN STANLEY7.1m1.21%−253.4k31 Mar 2026
BROWN ADVISORY INC7m1.20%−302.6k31 Mar 2026
DEUTSCHE BANK AG\6.1m1.03%+476.2k31 Mar 2026

Insider trades

Purchases and sales by directors and officers, as filed with the regulator

DateWhoTypeSharesPriceValue
2 Apr 2026 ↗BOBO DONALD E JRCVP,Strategy/Corp DevelopmentSale22.7k80.16$1.8m
11 Mar 2026 ↗Lippis Daniel J.CVP, TAVRSale1k85.38$87,004
11 Mar 2026 ↗Ullem Scott B.CVP, Chief Financial OfficerSale13k84.92$1.1m
2 Mar 2026 ↗BOBO DONALD E JRCVP,Strategy/Corp DevelopmentSale11.3k85.93$974,430
25 Feb 2026 ↗BOBO DONALD E JRCVP,Strategy/Corp DevelopmentSale24k83.84$2.0m

Short interest

Shares sold short, 15 Oct 2026. US exchange data.

9.3m

-2.1% on the period before. 2.5 days to cover.

Short volume

Share of the day's trading sold short, 4 Nov 2026

29.7%

Last 60 trading days.

Failed deliveries

Shares not delivered on settlement, from the SEC

  • 30 Sept 202674 shares
  • 24 Sept 202632 shares
  • 21 Sept 20264,800 shares
  • 9 Sept 202654 shares
  • 8 Sept 202694 shares

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.